46 results on '"Pyrimidines"'
Search Results
2. Vericiguat in patients with heart failure and reduced ejection fraction.
3. [Changes in the prognosis and treatment of Waldenström macroglobulinemia. Literature overview and own experience]
4. [Potential clinical benefit of therapeutic drug monitoring of imatinib in oncology]
5. [The place of JAK2 inhibitors in the treatment of myelofibrosis. An amendment to the recommendations for diagnosis and treatment of Ph negative myeloproliferations of the Czech group for Ph- myeloproliferative disorders (CZEMP)]
6. [RILPIVIRINE -- a novel HIV-1 non-nucleoside reverse transcriptase inhibitor]
7. [Tyrosine kinase inhibitors - major change in the prognosis of chronic myeloid leukaemia]
8. [Inhibition of B cell receptor signaling: a first targeted therapeutic approach for chronic lymphocytic leukemia and other B cell lymphomas]
9. [Another approach to targeted therapy of patients with metastatic renal carcinoma with progression in treatment with pazopanib:expert assessment by the Czech Cooperative Group for Metastatic Renal Carcinoma]
10. [To treat or not to treat with statins patients with chronic heart failure?]
11. [Combination of imatinib and anagrelide in treatment of chronic myeloid leukemia in blastic phase]
12. [Chronic myeloid leukemia--resistance to imatinib mesylate (Glivec)--literature review and personal experience]
13. [Imatinib--a new perspective in the treatment of tumors]
14. [Imatinib mesylate (Glivec) in treatment of chronic phase chronic myeloid leukemia]
15. [Chronic myeloid leukemia as a model for modern noncytostatic therapy of malignant diseases. From Virchow to STI 571]
16. OXIDATION PRODUCTS OF UNSATURATED FATTY ACIDS IN THE IRRADIATED ORGANISM
17. SMALL DOSES OF ULTRAVIOLET IRRADIATION AND THE FORMATION OF THYMINE AND CYTOSINE--THYMINE DIMERS AND THE INFLUENCE ON THE SYNTHESIS OF DNA IN MAMMALIAN CELLS.
18. ISOLATION OF AUXOTROPHIC BACTERIA.
19. STUDY OF THE PROTECTING EFFECT OF CHLOROQUINE ADMINISTERED TO GUINEA PIGS SUFFERING FROM SKIN DISEASES CAUSED BY X-RAY IRRADIATION.
20. INACTIVATION OF BACTERIOPHAGES BY HYDROXYLAMINE AND BY UV IRRADIATION.
21. CONTRIBUTION OF THE TREATMENT OF POSTIRRADIATION CYSTITIS, PROCTITIS, AND COLPITIS.
22. [The place of JAK2 inhibitors in the treatment of myelofibrosis. An amendment to the recommendations for diagnosis and treatment of Ph negative myeloproliferations of the Czech group for Ph- myeloproliferative disorders (CZEMP)].
23. [Report on clinical experience with antimycotic VUFB 9244 (Jopargin)]
24. [Treatment of hypertension in an infant with hemolytic-uremic syndrome]
25. [Synthesis and pharmacologic activity of pyrimidine derivatives]
26. [Clinical experience with 0.5% jaritin ointment and comparison of its effectiveness and tolerance with 1% haloprogin ointment (author's transl)]
27. [The synthesis and antineoplastic effect of esters of 5-(2-amino-4-oxo-6-alkyl-3,4-dihydropyrimidinyl) pentanoic acids]
28. [Effect of Sulfakombin SPOFA on the dynamics of the extent of coccidiosis in small rabbit breeding operations]
29. [A report on the clinical experiences from the comparison of the effectiveness of 0.2% and 0.5% solutions of the antimycotic agent VUFB 9244 (working name Jopargin)]
30. [Biochemistry of drugs. XX. Metabolism and disposition of the antifungal agent 2-methylmercapto-5-iodopropargyloxyprimidine(VUFB 9244) in rats]
31. [Our experience with Septrin in the therapy of urinary tract infections in chldren]
32. [PROBLEMS IN ACQUIRED RESISTANCE OF TUMORS TOWARDS CYTOSTATICS]
33. [Trimethoprim plus sulfamethoxazol in the treament of chronic infections of the lower respiratory tract]
34. [Treatment of refractory urinary infections in the aged]
35. [Experience with treatment of bacterial infections by an association of trimethoprim and sulfamethoxazole]
36. [Contribution to adverse effects of sulfamethoxydine (2-sulfanilamido-5-methody-pyrimidine)]
37. [CORRELATION OF THE ANTIVIRAL AGENT I914-VUFB WITH THE BACTERICIDAL EFFECTIVENESS OF SOME ANTIBIOTICS]
38. [Clinical evaluation of antibacterial chemotherapy in urology]
39. [Pyrimidine- and purine-type antimetabolites]
40. [Pharmacodynamics and pharmacokinetics of antibiotics and antibacterial chemotherapeutics]
41. [Sulfamethoxydin Spofa in the treatment of adnexitis (author's transl)]
42. [Effect of radiomimetics on the excretion of pyrimidine deoxyribosides of N-methylnicotinamide and N-methyl-3-carboxamid-4 pyridone in rat urine]
43. [Long-term intermittent therapy of chronic urinary tract infection using a combination of trimethoprim and sulfamethoxazole]
44. [Short-term therapy of urinary tract infections with a combination of trimethoprim and sulfamethoxazole]
45. [PROBLEMS IN ACQUIRED RESISTANCE OF TUMORS TOWARDS CYTOSTATICS].
46. [CORRELATION OF THE ANTIVIRAL AGENT I914-VUFB WITH THE BACTERICIDAL EFFECTIVENESS OF SOME ANTIBIOTICS].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.